Pig-to-Human xenotransplantation:Moving toward organ customization  

作　　者：Mengyu Gao Jie Zhang Rui Wang Guang Yang Ji Bao 

机构地区：[1]Transplant Center,Key Laboratory of Transplant Engineering and Immunology,Institute of Clinical Pathology,West China Hospital,Sichuan University,Chengdu 610041,China [2]SCMPA Key Laboratory for Quality Research and Control of Chemical Medicine,Chengdu Institute for Drug Control,Chengdu 610041,China [3]Experimental Animal Center,West China Hospital,Sichuan University,Chengdu 610041,China

出　　处：《Precision Clinical Medicine》2023年第2期119-120,共2页精准临床医学（英文）

基　　金：supported by the National Natural Science Foundation of China(Grants No.82070640 and 81770618);the Fulltime Postdoctoral Research and Development Fund of West China Hospital,Sichuan University(Grant No.2023HXBH039).

摘　　要：Dear Editor,Xenotransplantation is a potentially effective way to address the shortage of organ donors.The improvements in gene editing technology have accelerated a number of a breakthrough in genetically modifying pigs for xenotransplantation.In 2022,xenograft kidney transplantation entered the subclinical trial stage.

关 键 词：BREAKTHROUGH kidney HUMAN 

分 类 号：R617[医药卫生—外科学]